Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill P
Kenneth Norris Jr. Cancer Center, University of Southern California, Los Angeles 90033, USA.
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):455-60. doi: 10.1097/00042560-199504120-00004.
Kaposi's sarcoma (KS) is the most common tumor seen in patients with HIV-1 infection. HIV-1 may induce KS directly through viral protein(s) or indirectly through regulation of cytokines such as IL-1 and IL-6. We have shown that AIDS-KS spindle cells express IL-1 beta and that IL-1ra inhibits KS-spindle cell growth. IL-1ra had little effect on human umbilical vein endothelial cells (HUVEC), human aortic smooth muscle cells (HASM), and human foreskin fibroblast (NN41). These findings support an autocrine activity for IL-1. Furthermore, exogenous IL-1 can enhance AIDS-KS cell growth, and this effect is completely blocked by IL-1ra. As expected, IL-1ra also blocks IL-1 mediated upregulation of IL-6 and bFGF, both of which are autocrine growth factors for KS. IL-1ra is thus a potential candidate for the treatment of AIDS-associated KS.
卡波西肉瘤(KS)是HIV-1感染患者中最常见的肿瘤。HIV-1可能通过病毒蛋白直接诱导KS,或通过调节细胞因子如IL-1和IL-6间接诱导。我们已经表明,艾滋病相关卡波西肉瘤纺锤体细胞表达IL-1β,并且IL-1受体拮抗剂(IL-1ra)抑制卡波西肉瘤纺锤体细胞生长。IL-1ra对人脐静脉内皮细胞(HUVEC)、人主动脉平滑肌细胞(HASM)和人包皮成纤维细胞(NN41)几乎没有影响。这些发现支持IL-1的自分泌活性。此外,外源性IL-1可以增强艾滋病相关卡波西肉瘤细胞的生长,并且这种作用被IL-1ra完全阻断。正如预期的那样,IL-1ra也阻断IL-1介导的IL-6和碱性成纤维细胞生长因子(bFGF)的上调,这两者都是卡波西肉瘤的自分泌生长因子。因此,IL-1ra是治疗艾滋病相关卡波西肉瘤的潜在候选药物。